Abraxane
Pro00019321
Phase 2 small_molecule terminated
Quick answer
Abraxane for Metastatic Breast Cancer is a Phase 2 program (small_molecule) at Duke University with 1 ClinicalTrials.gov record(s).
Program details
- Company
- Duke University
- Indication
- Metastatic Breast Cancer
- Phase
- Phase 2
- Modality
- small_molecule
- Status
- terminated